Wayne Pisano bought stock once, on Feb 12, 2026

Wayne Pisano is a seasoned biotechnology executive serving as Chair of the Board of Directors at Oncolytics Biotech Inc. (ONCY), a clinical-stage company developing pelareorep, an oncolytic viral immunotherapy for cancer treatment.( He recently acted as Interim CEO before the appointment of Jared Kelly as CEO in June 2025, and on February 12, 2026, he purchased 30,000 shares at $0.84 each, increasing his holdings to 492,414 shares.(

Pisano brings extensive experience in vaccines and biotech leadership, including roles as President and CEO of Sanofi Pasteur (2007–2011) and VaxInnate Corporation (2012–2016).( He has served on the boards of multiple biopharma companies, such as Altimmune (ALT) since 2018, Provention Bio (until 2023), and IMV Inc. (until 2021), and holds directorships at Chattem, Inc. and River Acquisition Corp.( Pisano earned a B.S. in Biology from St. John Fisher College and an MBA from the University of Dayton.(

Written by Perplexity from public sources.